We are live on ! Find out more
PRVB

Provention Bio, Inc. Common Stock
PRVB

Delisted

PRVB was delisted on the 26th of April, 2023.

Back to rankings

106 hedge funds and large institutions have $294M invested in Provention Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

358% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 12

208% more call options, than puts

Call options by funds: $10M | Put options by funds: $3.26M

206% more capital invested

Capital invested by funds: $96.2M → $294M (+$198M)

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

68% more funds holding

Funds holding: 63 → 106 (+43)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
106
Holders Change
+43
Holders Change %
+68.25%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
55
Increased
30
Reduced
17
Closed
12
Calls
$10M
Puts
$3.26M
Net Calls
+$6.77M
Net Calls Change
+$6.32M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$27.8M
2
PA
Perceptive Advisors
New York
+$19.1M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$15.8M
4
State Street
State Street
Massachusetts
+$10.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$9.1M

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3.04M
2
SCM
Segantii Capital Management
Hong Kong
-$2.62M
3
OM
Opaleye Management
Massachusetts
-$1.53M
4
Invesco
Invesco
Georgia
-$1.08M
5
EGI
EAM Global Investors
California
-$917K
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$1.44M +$1.11M +87,667 +602%
Calamos Advisors
27
Calamos Advisors
Illinois
$1.36M +$1.21M +96,119 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$1.32M +$312K +24,728 +36%
Swiss National Bank
29
Swiss National Bank
Switzerland
$1.22M +$1.09M +86,100 New
Russell Investments Group
30
Russell Investments Group
United Kingdom
$1.11M +$994K +78,756 New
Two Sigma Advisers
31
Two Sigma Advisers
New York
$1.06M +$949K +75,200 New
Macquarie Group
32
Macquarie Group
Australia
$988K -$84.9K -6,725 -9%
EGI
33
EAM Global Investors
California
$982K -$917K -72,659 -51%
Group One Trading
34
Group One Trading
Illinois
$975K +$315K +24,950 +57%
State of Wisconsin Investment Board
35
State of Wisconsin Investment Board
Wisconsin
$959K +$859K +68,000 New
JGC
36
J. Goldman & Co
New York
$911K +$563K +44,595 +223%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$902K +$807K +63,896 New
Bank of America
38
Bank of America
North Carolina
$877K +$448K +35,521 +133%
SCM
39
Soleus Capital Management
Connecticut
$845K +$756K +59,900 New
SPC
40
Sigma Planning Corp
Michigan
$833K -$225K -17,840 -23%
WAM
41
Wealthspire Advisors (Maryland)
Maryland
$821K -$275K -21,800 -27%
SG Americas Securities
42
SG Americas Securities
New York
$817K +$731K +57,912 New
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$801K +$717K +56,772 New
VF
44
Virtu Financial
New York
$795K +$711K +56,339 New
AllianceBernstein
45
AllianceBernstein
Tennessee
$768K +$687K +54,400 New
EI
46
EAM Investors
California
$762K -$714K -56,524 -51%
CSS
47
Cubist Systematic Strategies
Connecticut
$758K +$348K +27,535 +105%
EGM
48
Engineers Gate Manager
New York
$680K +$608K +48,185 New
BAAM
49
Baker Avenue Asset Management
California
$667K -$284K -22,500 -32%
UBS Group
50
UBS Group
Switzerland
$660K +$265K +20,958 +81%
1
2
3 4 5

PRVB Hedge Fund Activity: Q2 2020 in Review

106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Provention Bio, Inc. Common Stock (PRVB) for Q2 2020, worth a combined $294M — up 206% from $96.2M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new PRVB positions and 12 closed out — a net gain of 43 holders — while 30 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock, adding an estimated $27.8M. The largest seller was Susquehanna International Group, cutting an estimated $3.04M.

  • 106 institutional investors held Provention Bio, Inc. Common Stock (PRVB) as of Q2 2020, up from 63 in Q1 2020.
  • Funds reported $294M of Provention Bio, Inc. Common Stock stock for Q2 2020, up 206% quarter-over-quarter.
  • 55 funds opened new Provention Bio, Inc. Common Stock positions in Q2 2020 and 12 closed out, a net change of +43 holders.
  • The largest Provention Bio, Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $27.8M added.
  • The largest Provention Bio, Inc. Common Stock seller in Q2 2020 was Susquehanna International Group, an estimated $3.04M sold.

Based on aggregated 13F filings for Q2 2020.